Stay updated on Nivolumab Combinations in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combinations in Urothelial Cancer Clinical Trial page.

Latest updates to the Nivolumab Combinations in Urothelial Cancer Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check42 days agoChange DetectedThe page has been updated to include new information about the drug Cisplatin and Carboplatin in relation to Urothelial Cancer, while significant details about the investigational immunotherapy study involving nivolumab and ipilimumab have been removed.SummaryDifference8%
- Check57 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check65 days agoChange DetectedThe web page has been updated to version 2.14.3, replacing the previous version 2.14.2.SummaryDifference0.1%
- Check101 days agoChange DetectedThe web page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Nivolumab Combinations in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in Urothelial Cancer Clinical Trial page.